4Sc Ag

Ilga Krimmelbein

Stefan Tasler

Mirko Zaja

Juergen Kraus

Jürgen Kraus

Compounds of formula (II) or a pharmaceutically acceptable salt or solvate thereof, the medical uses thereof for diseases or medical conditions where the inhibition of the voltage-gated potassium channel Kv1.3 is beneficial, and methods for their preparation.

KV1.3 inhibitors and their medical application

Kv1.3 inhibitors and their medical application

The present invention relates to a compound of the general formula (III) or a salt, solvate or prodrug thereof, as well as medical uses involving them,  wherein A, A, A, A, A, A, Y, Rand Rare as defined herein, and methods for producing such compounds.

Growing community of inventors

Munich, Germany

Ilga Krimmelbein